Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
2595
□ CASE REPORT □
Pseudo-Meigs’ Syndrome Caused by a Krukenberg Tumourof Gastric Cancer
Takahiro Horimatsu 1, Shin’ichi Miyamoto 2, Yoko Mashimo 2, Hiroshi Okabe 3,
Yoshiki Mikami 4, Tsutomu Chiba 2 and Manabu Muto 1
Abstract
A 50-year-old woman who presented with a one-month history of abdominal fullness and dyspnoea was
admitted to our hospital. Esophagogastroduodenoscopy showed the scirrhous-type gastric cancer on the
greater curvature of the gastric body. Computed tomography revealed bilateral large ovarian tumours with
massive right pleural effusion and ascites. A repeated cytological examination of pleural effusion and ascites
revealed no malignant cells. The definitive diagnosis of pseudo-Meigs’ syndrome was made by confirming
the fact that pleural effusion and ascites disappeared after bilateral oophorectomy. Resection of ovarian tu-
mours may also lead to long-term survival, even in the patients with pseudo-Meigs’ syndrome caused by gas-
tric cancer.
Key words: pseudo-Meigs’ syndrome, gastric cancer, Krukenberg tumour, oophorectomy
(Intern Med 54: 2595-2597, 2015)(DOI: 10.2169/internalmedicine.54.4088)
Case Report
A 50-year-old woman who presented with a one-month
history of abdominal fullness and dyspnoea was admitted to
our hospital. Esophagogastroduodenoscopy showed
scirrhous-type gastric cancer on the greater curvature of the
middle gastric body (Fig. 1A). A biopsy specimen revealed
a poorly differentiated adenocarcinoma (Fig. 1B). Computed
tomography (CT) revealed bilateral large ovarian tumours
with massive ascites (Fig. 1C, D) and para-aortic lymph
node swelling. A chest X-ray showed right pleural effusion
(Fig. 2A) and the coronal section of the CT image showed
right pleural effusion and ascites (Fig. 2B). The laboratory
studies indicated that the serum carbohydrate antigen (CA)
19-9 and CA125 levels were 559.7 U/mL (normal range,
<37) and 489.8 U/mL (normal range, <35), respectively. No
peritoneal metastasis was detected by CT, and a repeated cy-
tological examination of the pleural effusion and ascites re-
vealed no malignant cells. Because the ovarian tumours
caused pain and debilitation, palliative oophorectomy with
the removal of ascites was performed without neoadjuvant
chemotherapy (Fig. 3A). The histopathological findings re-
vealed the presence of poorly differentiated adenocarcinoma,
which was similar to the gastric cancer of the primary re-
gion (Fig. 3B). After oophorectomy, the pleural effusion
vanished immediately (Fig. 4), suggesting pseudo-Meigs’
syndrome (P-MS). Subsequently, systemic chemotherapy
was initiated. Because marked tumour shrinkage was
achieved after seven courses of TS-1/CDDP therapy, distal
gastrectomy was performed (1). However, peritoneal metas-
tases were confirmed during surgery. Despite the continued
systemic chemotherapy (TS-1→paclitaxel→irinotecan), the
patient ultimately succumbed to the disease 27 months after
oophorectomy. No re-accumulation of the pleural effusion or
ascites was observed until peritonitis carcinomatosa devel-
oped.
Discussion
In 1937, Meigs and Cass described Meigs’ syndrome
(MS) as a benign ovarian fibroma associated with ascites
1Department of Therapeutic Oncology, Kyoto University Graduate School of Medicine, Japan, 2Department of Gastroenterology and Hepatology,
Kyoto University Graduate School of Medicine, Japan, 3Department of Gastrointestinal Surgery, Kyoto University Graduate School of Medicine,
Japan and 4Department of Diagnostic Pathology, Kyoto University Hospital, Japan
Received for publication September 10, 2014; Accepted for publication February 9, 2015
Correspondence to Dr. Shin’ichi Miyamoto, [email protected]
Intern Med 54: 2595-2597, 2015 DOI: 10.2169/internalmedicine.54.4088
2596
Figure 1. Scirrhous-type gastric cancer was located on the greater curvature of the middle body (A). A biopsy specimen revealed poorly differentiated adenocarcinoma (B). Computed tomography revealed bilateral large ovarian tumours (C, D).
Figure 2. A chest X-ray showed right pleural effusion on admission (A). The coronal section CT image showed right pleural effusion and ascites (B).
Figure 3. Macroscopic findings of the resected ovarian specimens are shown (A). The histopatho-logical findings revealed a poorly differentiated adenocarcinoma, which was similar to the gastric cancer (B).
Intern Med 54: 2595-2597, 2015 DOI: 10.2169/internalmedicine.54.4088
2597
Figure 4. The pleural effusion vanished immediately after oophorectomy.
and hydrothorax that resolved on removal of the fibroma.
Meigs distinguished the definition of MS from P-MS ac-
cording to the histology of the primary tumour (2). He at-
tributed the name P-MS to pelvic pathology other than be-
nign ovarian tumours that caused the same clinical pic-
ture (3). In 1950, Dick et al. reported the first case of P-MS
caused by a Krukenberg tumour of gastric cancer (4). Since
then, only eight cases have been reported: two cases in the
English literature (4, 5), two in the Japanese literature (6, 7),
and four in Japanese proceedings. Characteristically, the on-
set age is relatively young and all of the pathologies were
the diffuse-type gastric cancer. Pleural effusion is more
prevalent on the right side, and the ovarian tumour is pre-
dominantly bilateral. The final survival times previously de-
scribed in the literature were 32.5 (5), 27 (present case), and
17 months (7), which is longer than typical for stage IV
gastric cancer (median survival time of approximately12
months). These reports suggest that resection of ovarian tu-
mours may provide not only a palliative benefit, but also
lead to long-term survival in patients with and without P-
MS (8, 9). However, the reason why resection of ovarian tu-
mours may lead to long-term survival remains unclear. One
possible reason is that metastasectomy for ovarian tumour
often leads to the improvement of the performance status,
which makes it possible to continue adequate systemic che-
motherapy.
In conclusion, gastric cancer with metastatic disease to
the ovary may result in P-MS. The recognition of this syn-
drome may allow for a prompt diagnosis and appropriate
treatment, including resection of the ovarian tumours.
The authors state that they have no Conflict of Interest (COI).
References
1. Satoh S, Hasegawa S, Ozaki N, et al. Retrospective analysis of 45
consecutive patients with advanced gastric cancer treated with
neoadjuvant chemotherapy using an S-1/CDDP combination. Gas-
tric Cancer 9: 129-135, 2006.
2. Meigs JV, Cass JW. Fibroma of the ovary with ascites and hy-
drothorax: with a report of seven cases. Am J Obstet Gynecol 33:
249-266, 1937.
3. Meigs JV. Pelvic tumor other than fibromas of the ovary with as-
cites and hydrothorax. Obstet Gynecol 3: 471-486, 1954.
4. Dick HJ, Spire LJ, Worboys CS. The association of Meigs’ syn-
drome with Krukenberg tumors. NY J Med 50: 1842-1843, 1950.
5. Cetin B, Aslan S, Akinci M, Atalay C, Cetin A. A long surviving
case of Pseudomeigs’ syndrome caused by Krukenberg tumor of
the stomach. Jpn J Clin Oncol 35: 221-223, 2005.
6. Okazaki Y, Yonezawa K, Shimomatuya T, Komai Y, Yukioka N. A
case of pseudo-Meigs’ syndrome caused by metastatic ovarian tu-
mors from gastric cancer. Nihon Shokakibyo Gakkai Zasshi (Japa-
nese Journal of Gastroenterology) 106: 529-535, 2009 (in Japa-
nese, Abstract in English).
7. Miyata R, Hosoda Y, Hashimoto M, Ko J. A case of gastric ade-
nocarcinoma presenting pseudo-Meigs syndrome. Nihon Rinsho
Geka Gakkai Zasshi (Japanese Journal of Gastroenterology) 65:
508-513, 2004 (in Japanese, Abstract in English).
8. Cheong JH, Hyung WJ, Chen J, Kim J, Choi SH, Noh SH. Sur-
vival benefit of metastasectomy for Krukenberg tumors from gas-
tric cancer. Gynecol Oncol 94: 477-482, 2004.
9. Lu LC, Shao YY, Hsu CH, et al. Metastasectomy of Krukenberg
tumors may be associated with survival benefits in patients with
metastatic gastric cancer. Anticancer Res 32: 3397-3401, 2012.
Ⓒ 2015 The Japanese Society of Internal Medicine
http://www.naika.or.jp/imonline/index.html